Takeda K, Inoue H, Tanizawa Y, Matsuzaki Y, Oba J, Watanabe Y, Shinoda K, Oka Y
Third Department of Internal Medicine, Yamaguchi University School of Medicine, Ube, Yamaguchi 755-8505, Japan.
Hum Mol Genet. 2001 Mar 1;10(5):477-84. doi: 10.1093/hmg/10.5.477.
Wolfram (DIDMOAD) syndrome is an autosomal recessive neurodegenerative disorder accompanied by insulin-dependent diabetes mellitus and progressive optic atrophy. Recent positional cloning led to identification of the WFS1 (Wolfram syndrome 1) gene, a member of a novel gene family of unknown function. In this study, we generated a specific antibody against the C-terminus of the WFS1 protein and investigated its subcellular localization in cultured cells. We also studied its distribution in the rat brain. Biochemical studies indicated the WFS1 protein to be an integral, endoglycosidase H-sensitive membrane glycoprotein that localizes primarily in the endoplasmic reticulum (ER). Consistent with this, immunofluorescence cell staining of overexpressed WFS1 showed a characteristic reticular pattern over the cytoplasm and overlapped with the ER marker staining. No co-localization of WFS1 with mitochondria argues against an earlier clinical hypothesis that Wolfram syndrome is a mitochondria-mediated disorder. In the rat brain, at both the protein and mRNA level, WFS1 was found to be present predominantly in selected neurons in the hippocampus CA1, amygdaloid areas, olfactory tubercle and superficial layer of the allocortex. These expression sites, i.e. components of the limbic system or structures closely associated with this system, may be involved in the psychiatric, behavioral and emotional abnormalities characteristic of this syndrome. ER localization of WFS1 suggests that this protein plays an as yet undefined role in membrane trafficking, protein processing and/or regulation of ER calcium homeostasis. These studies represent a first step toward the characterization of WFS1 protein, which presumably functions to maintain certain populations of neuronal and endocrine cells.
沃夫勒姆(DIDMOAD)综合征是一种常染色体隐性神经退行性疾病,伴有胰岛素依赖型糖尿病和进行性视神经萎缩。最近的定位克隆导致了WFS1(沃夫勒姆综合征1)基因的鉴定,该基因是一个功能未知的新基因家族的成员。在本研究中,我们制备了一种针对WFS1蛋白C端的特异性抗体,并研究了其在培养细胞中的亚细胞定位。我们还研究了它在大鼠脑中的分布。生化研究表明,WFS1蛋白是一种完整的、对内切糖苷酶H敏感的膜糖蛋白,主要定位于内质网(ER)。与此一致,过表达的WFS1的免疫荧光细胞染色显示在细胞质上有特征性的网状模式,并与内质网标记染色重叠。WFS1与线粒体没有共定位,这与早期的临床假设相矛盾,即沃夫勒姆综合征是一种线粒体介导的疾病。在大鼠脑中,在蛋白质和mRNA水平上,发现WFS1主要存在于海马CA1区、杏仁核区、嗅结节和新皮质浅层的特定神经元中。这些表达位点,即边缘系统的组成部分或与该系统密切相关的结构,可能与该综合征的精神、行为和情绪异常有关。WFS1在内质网的定位表明,这种蛋白在膜运输、蛋白质加工和/或内质网钙稳态调节中发挥着尚未明确的作用。这些研究是对WFS1蛋白进行表征的第一步,该蛋白可能起着维持某些神经元和内分泌细胞群体的作用。